PATENT CLAIM ANALYSIS

Application Number: 16136318
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-06
Patent Classification: ["514", "423000"]

Abstract:
Provided is a pharmaceutical composition for treating a renal disease. The pharmaceutical composition for treating a renal disease comprises a mineralocorticoid receptor antagonist.

Claim (Index 9):
The method according to  claim 1 , wherein the mammal is a human.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 97.0
- Lexical Diversity: 1.66667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15723097', '14928048', '13766266', '13979127', '14079464']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7102045540187204
- 35 USC 102 Novelty (BERT): 0.5225633549825073
- Combined Prediction Score: 0.691440434115099
- Mean Citation Score: 245.69522800000004
- Max Citation Score: 307.4534
- Similarity Product: 240.6325065792084

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test